Why Doximity Stock Is Skyrocketing Today [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
the company reported fiscal second-quarter earnings for the period ended Sept. 30. Home to the leading digital platform for healthcare professionals in the United States, Doximity grew sales and earnings per share by 20% and 47%, respectively, while providing improved guidance for the full year. Following the company's revenue growth decelerating from over 90% in 2021 to just 6% only two quarters ago, the market seems optimistic that Doximity's accelerated growth could be here to stay. Start Your Mornings Smarter! Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Used by over 80% of U.S. physicians, 60% of nurse practitioners, and 90% of graduating med students, Doximity's reach in the healthcare community is unmatched. Doximity offers a personalized news feed for its 2 million members -- which grew by double digits in Q2. The company set a new record for the number of articles read, highlighting its burgeoning engagement. Thanks to this engagement
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity, Inc. (NASDAQ: DOCS) had its price target raised by analysts at JPMorgan Chase & Co. from $30.00 to $48.00. They now have a "neutral" rating on the stock.MarketBeat
- Zacks.com featured highlights Doximity, Impinj and Innodata [Yahoo! Finance]Yahoo! Finance
- TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Yahoo! Finance]Yahoo! Finance
- TikTok ‘dermfluencers' have medical students flocking to dermatology, where they can make half a million dollars a year and work four days a week [Fortune]Fortune
- Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors [Yahoo! Finance]Yahoo! Finance
DOCS
Earnings
- 11/7/24 - Beat
DOCS
Sec Filings
- 11/15/24 - Form 4
- 11/15/24 - Form 4
- 11/14/24 - Form SC
- DOCS's page on the SEC website